R•gl•t•rnd numb•r. 0824091J Charlty nun*. 1149768 ARK CANCER CHARITY (A Company Umltod by Guardntoo) UNAUDrrED TRUSTEES. REPORT AND FINANCIAL STATEIAEKrs FOR THE YEAR ENDED 31 DECEMBER 2023 9-10 B*lanc• She•t 12-13 14-28 AIIK CANCER CHAIUTY (A CoNyny Llm*•d ty Guarants•l REFERE14CE APXI ADIAINI8TRATIVE DETAILS OF THE COMPANY. rrs TRUSTEES AND ADVISER3 FOR THE YEAR EMI￿ 31 DECEMBER 2023 Trn•t• MR9 S Fell. Cha R Firfayson l Hathson {8FWWrted 28 Juno 2023) Company r•glstsr•d numb•r 08240913 Cha￿Y r•gknt•r•d numb•r 1149758 Company ¥•¢r•tary B DevereL¢X Accounlants ARK CANCER CHARITY TrUSTEES REPORT FOR THE YEAR ENDED 31 DECEAIBER 2023 The Twstees IT*kn arg alw direct￿ oftr* Ch* ky the pws•5 cl tho Co[￿8￿•$ wesert thelr ￿nu01 report, Whlch 1$ also the direL*orf T•P(rt together the fnwual slatements of Cancer Centre Charity (the company) for the ye* 31 December 2023. Tho Twstees confiTh that the Pl7nL￿1 Report and Fin￿claI Statemerts of thè company conwy with ts twgnt stalutory reqLIr8M￿ts. the rerylr•ments of the companfs pverring dO￿rnent thè proviwn$ of th• Ststement of RecommwKlgJ Prnctre (SORP) "ACoxm￿9 and Rwirlir¥J by Ch*$" 2019). Slnce the Com&wy 8$ small ￿¥jer 383. th• stra￿ Repyt rewd of methum ond Iwge C￿nI&S wxler Ihe C¢mp￿Vas kn12(1% {Str*G Rff•yt w•J Re￿rtI Rog￿￿n$ 2013 1$ n¢X requirèd. • Stvuctsr• Ajk Cancer C•ntre C￿ty is a Limthj ty Guarwkne (No: 8240913) a ¢1￿14ty Registered in Englond arKI W4les {No". 11497S8). ft is gtr4wrwd ty ts MemcrfaThlwn Arbd8s ofAsgocialion. Thg Trustees onstitute Direct￿ oftha Charity forlho FrfXF￿es ofcoryyany law. Ark Cancèr Centr• was re￿red as • 41h Octs)bw 2012. ft was r¢pt•r8d as a charity on 14th November 2012 and as a result a￿0ved to rts r￿& to Ark Cancer C•ntr8 Charity on 26th November2011 Emrknasis is ￿ed thè sk* of to Tnth, f￿1 to th& Charitys devolopThnL • Manag•mont Th• management of Ch•ity d•thcated to enhanco the expen•nce of cancer pabènts r•caivlng trpatment at Haryshlre HOS￿￿1 Fo￿d811￿ TfttsL Thrw the grants wjhcy. vrt are ablo to fvnd Iho Communution: Tho Trustees IPA Ihe •mB ofth• Clwuy we TAth accur•cy dwity to I Fknanca w#J *Jm1iistrabf￿". minag8d by the Tmstees. P•J• 2 ARK CAIKER CHARITY IA Coryany LIn￿d ty Gu*rantsèl TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDELI 31 DECEh*ER 2023 Stru¢tsre, manag•mont and gov•rnanc• 1Gonlkny￿) • Gov•manc• The relief of slthnw arnl tt)e weservatk)n ol he*1 *d to assi* in the treaiment *KI care of persons afferaad by ¢anCerthr￿9h the o￿an¢9m0nts olal aspects of care I￿1￿￿￿9. prwding iy assisting of equ¥Mnthi( f•akI￿S serv[￿9 or to WO￿￿¢ or ￿181 in the wovisc¥) of ftm¢thng tr etharKod or imwoved fjtttng c￿1 and d9Ctyat￿n or any improvwnent to the a8slh8tie aspects ofnow or eyisting ¢￿￿Or ¢gr• caitre¥ run by the statsjtuy authxities ry other care yovidors to enh￿ th& wellbeing of peTron8 affect•d by providlr¥J or as$￿IK¥j in tr* prrmsicffi ot ¢X proVw￿9 funthg for slatutw aut1￿111•$ or other car providers lo prowdè. andl•y ￿ni￿O￿nIary car• wvice8 arKI th9r41i￿ to enha￿8 the Ihwr carern, familios carers, fam*es and friends. The furtherance of obieds purpoges to be ￿led in Norlh H*np8hlre or general￿ in the Lkniled ngdorn being abjocts and PLwwses are exdusivaty chariloble ac£¢qlTr3 l** ot England and Wales. 2. Put4c 8￿Offl The Charlty has looked a ths ber*ffls of ts Ltier*ves aTrJ has Co￿￿1 Ihat there Is 8iwificwrt ovidence htghlighting that offthing treatrnent in a ￿aSant. int•resbn9, irmvatNe environment t*nefits patients and gre￿1 iFrw)¥es tho OLrtcom ottheir Iro*￿￿ The gr¥ts ensuro the provision ofr. Se￿1￿ wlhln an ex¢epllonal $8ttwig eTr4ironM￿I ￿1p to elev*g the psychologlcal W8Uness of patients and thew fami58& EvpJence Substw￿aleS thoso •thnlnlstering treatments ¢er trealmenL A range ol wpport therws. i.e. psyo*cal wpport, WP4tvcthry> ¢ours95, Xcgss lo h8*th, frtness. complamaw th8rop*s. etr. Flus L￿p¥ehensive infomatM rescAffces. The8e S&￿e5 enabl8 patients to m*ago Iher (wllkn and treatm￿rtIO assist peoplo livtng with t￿cer arKI Ihew familie$. In SWIM￿ the putlc benth OlA￿ Cwkni Is lo ensw• thal fxllbes a¥￿lab￿ for anyone W+tri needs support. ￿ether rKeW or are famity membws gn9agfjd in SLPW￿n9 a s￿rer dwing or aft& th￿ tra•1m￿L ARK CAIKER CHARITY IA Company UMtt￿ by auarnnt••) TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023 str￿lUT•. minag•m•rt and gov•m•nc• Icortknwdl Therth tho Trusteos belipve IfAt Itv Iw¥e ccrfnF4&J to have kn rtyard io putltshed by the ConYrriswL Plan• forluthn p•rh)d• the support they need. • Grnnt maklng pomcy Funithng Is madè availat49 to Ha)Wirn Hcryxl* NHS Founrjation Tn*t via gr•*s. Grants arg made to Hamp8hire Hospll* NHS Trust at Tn*t*s' (*sry01•)n. The Truste￿ 8$58ss an b*Js from Hampshke Hos$Nta￿ NHS F￿nd￿￿on Tntst tD er￿? ty￿t the Charty wc¥Jld not b• $LsbstitutAVJ Olher fvTrJiTrJ sources for stanuafd pro¥i*on but be ceirwJ Contra has w*b¥ely imp*d the commuimty by F*ovithng need*J $upF¥￿t seryicos to cancai pthn￿ succw rafi•th our dpM8e raryo of 59ryl¢es, ￿¢ourageMent sellin9 WVKaS to ￿¢￿r pabwts ￿ th• HHFf ar•a. Sorvmig a wid8 ran￿ ofcancgr pabgnts, Ito C•ntre d•monstratss ts ability to calar to dIVe￿e needs. incknling ￿¢8$1, gyipecolw"¢al. ha￿at￿8￿. prDState. oJk>r8¢Aal. upp•r gastrointostinol. lu By offerfng compkner• trw•les akn&sAae conTMttkJnal medical ¢ar•. prcfflotss healing thal erwmpasses bcth *tywcal emth¢)￿l Patignts frc¥)) a cornwphw￿IYe apwoath that addresses Ireatrrf side effects emoUThwl thalknges. rn. Thew adherence lo NHS guidefmes ar¥J c4rNcai u)leaguos W￿ureS that patient By ¢oThethg and ublsing patlwrt feedbad¢. the centre dgmonstrates Its commitrnent to wtting patlents at the forefront of its ser¥w. apyoath n(* cdy irryrovè$ ¢>re wality bul al$0 offgrs in$wJhts to HHFr Highlight•J thrwh varirJJs cage 8bJdies. thè Catr's thtrapw ha¥0 led to poslb've outcomes such as alleviating treatment smle effects, post•0￿0 recovwy. aThJ S￿￿￿'n9 patients Ihrough ¢haltfjngirwJ tr•*n•rrts such as rathother4ry. Vlb'maloty. the Cenkn'5 key inwlas *) (Neral *l)8ing for cmr paliants. IhrTrJgh offwirwJ effective 10018 to mana9& tre￿nefit￿ thalgn99s and wnoti¢x41 strakn. the Contre contrbutes 10 imwoving palienl$' quakty of lifg Ihair carKeritiumey. ARK CANCER CHAiurY TRUSTEES. REPORT (CONTINUED) FOR ThE YEAR ENDED 31 DECEIABER 2023 Aehl•v•m•th and p•rlomwnc• Iconlknu•dl Ourwwj summer of 2023. th• cthaiity d￿d￿d tr* wthrtak• 8 [•r￿¥th of lh• •xstviq eh8mothwapy Basirytoko Hospitsl. orisinalty de5iW aB a this spaco wa$ repur[￿Sed lor ¢￿￿th*rapY durlNJ tho recert parthrn￿ to ansurn Ihe saf* of pati8nts aTrl ￿aff. Recognising th• suc£ess of arrangement, the Ath Canw Charty 1$ now embathg on a 8ignilcart r•*Jfbl8hment to ueato a n￿re Colltbxallng a team of ￿eth. the Ch￿ty has conthjctod a feasi￿71￿ stuty lo plan Ihe rwovation. Th• North Hampshire H05Prtal has appointed As Estate Prr4ecl Manager and cfmlcal Ptwt Manager to Gre8nh￿ T￿￿t has agreed tr) fd•as8 ts £sCQ.0￿ of match lurwjing wevhx*ly raiud ttYwJh thelr fundralslng F4adomi by wpporbvo ofth c￿cer Chaiity. n¥$ wil be directed towards the In to Ilw oThJrAfVJ bewN uvjertth by lh• tharity. we we pl088￿ to rowt a $gnrfl¢ant to th8 Chgmothwapy Departrn•nt at 8asiry5toke. Sp•offc•lty. have donated a Hdothemi Machine to **Jress chalero•s associated *ith c*￿m￿Py￿￿ucad Feli[￿￿ neuropathy {CIPNI M14crfrt S￿droMe (HFS}. Chemclher8py. 8 aspecl of Iteatria* okn leads to various SKle effects, CIPN ￿Ing a wel known cc¥Kem. This cJxdIb￿ pr•drynAiarlly all￿ts th? and feet of ¢Xrtor patients. resuliing in sev•r• paln. thscomfort, Ilw￿￿J. numbness, and balance issue¥. Adtht•. exposwe lo certsin ¢￿therapY drL uso haTr*fts)t syndrthne (HFS). a domwtob?cal corthcffi chwa¢twtsad by r•drn￿, nunbn•88. 1lTr3. NstedTrJ. a￿1 dry. pgekrvj skwi i)n the pakn$ sole& CIPN and HFS. We we deTh￿d to *￿e b¢on amoTrJ the firnt to this mathne to thè h¢)sprtal, anowy tt to cortht Its rAYn sludy ￿ Ihe efficacy ol the equipmert This SpeC￿C unit was made Fthsiblo thrwgh thè generous donali¢M by Th• Ethna L8¢xM>Ta ch11th￿'S FowKlaticffl. ARK CANCER CHARITY IA Coryany Llmit•d by Gtsarnnl••) TRUSTEES. REPORT (CONTINUE FOR ThE YeAR eNDED 31 DECEIIBER 20Z3 A¢hl•v•m•nts •nd p•rformanc• (contIn￿} • Fundr*lslng acllvlty ov•r th• p•Jty•ar Thrc4Jghout the yw, our dwity fvrKtratsiw efforts hia online plattttms has I￿01¥•d nsi$tent suppyt from ¥￿0v$ Comm￿￿ty S￿.50 nliativo has mathin8d its powlarity. contrfrmthhig to ¢)ur fuThjrai￿Thj sutt8SS. will ovarw th? than￿5 fiTAncial matters going f￿[d. An additwal memb8r of thg Tr￿le0 Board Is also In . Furthèm¥Jr•. wo are n th8 F¥r￿4S5 d hviTrJ a d8rhcaW FunthalsiNJ ma￿5er to enhance cAJr capabilitigs in tris ¢ru¢ial area. Novernb8r. ￿ wwe Ihrw lo H•allh & WeknTNJ Charlty ofth$ Y8¥A¥Md thjring the inougural Greenham Trust Ch81ty Awards Ceremw n N￿￿ry. This presb"gious recognition stands as a ts8taryRnt to the meliodous planning by our Charlty aTrJ Wd*elNJ team. Additionany, it underscm¥ tho LThYdvering SUPPOrt we h8¥e re¢ei¥ed from the gen￿u$ th)nabons contllblrtgd by the public. This award not oyfy ¥kntrA8dg0$ th• sxtstardTrJ athlwem•nts of ￿ Chaiity Ixrt also lighlwJNs the positNe extend ￿r heartrel gatitud• to everyw invc4¥•d- our declcated team men)bets. suppyter¥. and the commurnty at largg. Ths rwniiion inspiro8 US to cunknuè our fundraisir#J wkn renewed vi9wr. krK)y￿n9 that our ¢ollecti¥¢ efforts ar8 makirwj a meanir#JfiA dffiere￿e in the ofthose ￿ sorv8. we look fopwaTd to 0)ntin￿ng ourjournoy uo8try 8 Impacl in tho communty. Smal noto In pl￿￿n9 Ihis repcrt thg dlrecl(vs have tkn atrantay• ofth¥ wnal c4ry¥i95 gxwrytion$ P￿￿ded by sect1￿ 415A ol the Comwiey Ad 2rJJ6. )proved by ordor oftho ofth• bo¥d rfTru#•es aNI ¢)n th•tr bth8lfty. ftjl S Fell Trustee ARK CANCER CHARrri STATUENT OF TII(ISTEES' RESPONSIBILMES FOR THE YEAR ENDED 31 DECÈMBER 2023 The Trustees Ivlts r*• aso thè direc￿$ d th• for ts wpose$ of oxryany lawl are respon81ble f •poring the Trustees. Rwrt aTrJ tha fmancial In *c¢*dar￿a *qth appl¢ab￿ l*v aThl Ur￿1¢d ng(k)m A¢cow￿ng Standards {UnthJ Klr9kn) Grn*y Attepted AccoLmknng Pracbco). TruBtees ￿￿￿1 not apwovo the financial Stat8M￿ uthss W ar8 sausfjed Ifot tsy a true and falr of the state of affair3 of thg coM￿nY ¥md ol its w￿(¥ning re8￿j￿5 of resourc￿, induding its kncorne and gKp•nd#ure. fc* that whjd. In Fry>arirvJ these statem￿, ts Tn￿l￿e5 are requtred to.. rtiser¥e the methods 8nd prThwl•s ol the Charitles SORP (FRS 102)". make j￿19M9r￿S and ￿nting eslimth that •• reayonabte ￿￿j￿n[ state appllcable UK AtC4xxty Stwdards {FRS 102) tra¥e bgen fiSlowed. subFd to any materfal departur•s 15$d￿d and explained kn the fIr￿ClaI ststements; rry¥e the flnancoal sl*emwrts on 90ry c4ncom ba$s wless it 1$ Inwopri8te to pr•stThe that th6 the transactlons discknse witt) reasonth accurw * ary tima thè fmanrial of the Company enable to ensure that th• finan¢Tr81 Slatements compty Ihè Compani8$ Act 2006. Th•y *0 responsible for SaI￿arth￿3 the 8559ts ol the aThl herK8 fortth'ng réasonabb $lèps for preventson detsctKin of fraL•J a¥J other irrg¢Jul•ii*s. Approv•d by orthrofthe 01t￿ bo¥d ￿Trust08S *MI * on bthall ty.. S Fell Tru3ts• spoil. .Iql2Ltr Page 8 IA Coryany Llmlt•d ty Guarnnt••) INDEPENDENT EXAMP*R8 REPORT FOR THE YEAR ENDED 31 DECEIW 2023 Ind•p•ndent Examlnerf* R•wt to th• Trust••s olArt Canc•rCh¥lty Ilh• Comp•ny? I report to the tharmy TnAl•e8 my examiwkn of the accou￿ of ts COrTv￿ br the year ended 31 Decqmb•r 2023. R••ponslblMtl•s and Basls ol R•port As th TnJst•es of tha Ckvnpany {*xl its fiy the ofc¢xnpany law) y Thx wl crf assume responslLIUty lo ￿yone othw than Crynpany the cor1v￿$ Trustées as a bw. my TAyxk or for Ihls rwL 109 ) 2£)l* Mark Thc*in5 FCA ShawGlbbs IAudlQ Lknll*d Unl¢)n Roal Farn￿M Surrey Gug TrT Page10 ARK CANCER CHARITY IA Company Limlt•d by Guar*nt••) STATEMENT OF FIMAPICIAL AC7MTIES {INCORPORATING INCOME AND EXPENDITURE ACCOUND FOR THE YEAR ENDED 31 DECEMBER 2023 Unr••trlrt•d funds 2023 T*)lal nds 2023 Total 2022 Com• froTh." Donabon$ and IW$ Othertrading athbes Investrnerts 37,416 301175 69.541 37.415 30,078 69,541 117.L 24,695 13,026 Total knc¢)m• 137.031 137.031 154. 730 Exp•ndkn on: Raising fvnds Chwilable •th¥ili•g 1614 139.087 2,614 139,087 3.159 201.626 Totsi •xp•ndlturn 141,701 141.701 204.785 Ngt n￿•rn•nt In fund 14.$70) 14.6701 (50,055) Ro¢onclliatw)n of fvnds: Tota fimds brtwhl Net rnovement in ftvKIs 1660,587 . 2,660.687 14.670) 146701 1710,642 ¢￿,055) Tow fvnd¥ ¢•ryigd forwArd 2,665￿17 2.164917 2,660,587 The nolas t)n page$ 1410 28 fomi wt ollh88e st*eM￿ts. ARK CANCER CHAiirrY IA Cwnp•ny Umll•d ty GuiThnt••> REGISTERED NUM8eiL. 08240913 LANCE sTrEEr AS AT 31 OECEMBER 2023 2023 2tr22 Flxgd amots Tang4bl8 asséts Curr•nt 11 12 13 9,053 I￿2016 831,506 Inveslmerts Cash at bwk harbj 10S8.$96 677.932 1746.366 1842.575 14 197AS8) (183,788) N•t ¢urff•nt 48sats 2658, T87 Total as••ts Gurr•nt 1*bH￿S 2MS,918 2.660,58T N•t ••s•ts •xcludlng p•nsl¢)n •¥¥•t 1664918 Z660.587 Tot•1 n•t I￿•ts 2.666.918 2,660.597 Ch•rlty fvnds Restricted frthJ8 Unroslriei•d IwKts Is 15 2.660,587 Total 14nd* 1656.918 2.66Q.58T Pa98 12 ARK CANCER CHARITY IA Comp•ny Llmlt•d by Guarant••) REGISTERED NiKA8eR: 08240913 BALANCE SHEEf ICOMTINUED) AS AT 31 DECEIABER 1023 Th• COMP￿ was Ontilled to exen4XKMI fmm ￿¥Jer 4TT afth• Cofflpanles Act 2006. The members have Th)t require(l thè cxryary to otthn for ts yw in q￿stion ￿ accLYdance ￿th thè small conyii•8 r•gm•. Th• rYw￿•1 st*•m•nts wffo apK¥owJ au￿NiTed flx i5SU8 Trusts8s and slgned ￿ their behdf by.. S F•ll Twst Spkii iolql24 Pag• 13 ARK CANCER CHAIIITY NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEM8eR 2023 G•ner•l IAfom Canw Chwbty (fom*ty Cancw rs • piiv* comp*ry. limit￿ by guarantse thwt ¥h¥e ￿$￿tal irt4rpry*ed in Ils registwod offiGe adthgss h The Ark C￿￿ce Centre, Dinv•Yxxli• ttri¥è. Ba3￿gStOke. Hwnpshye. RG24 9NN. A¢counllng pokl 2.1 Ba•ls ol prnyratk)n o(Ilnancl•l strt•n The f￿￿l￿al st*•m•ts h8¥8 be￿ tAvlh Ih* Char#*s SORP IFRS 1021 . A￿nting and ty Charttle8.' Ststemwrt ¢￿ RK0mm￿4Od Practic• applicabl8 to eharthes preparing th￿r acc￿rtS in ￿C(w￿an¢e *tyth the Financ￿ Reportirg Standard applicablo in thg UK and R•pubk of Ireland IFRS 102) leffocbve 1 JaNwy 20191. tr* Financial Rèpth"ny StsTrJard appl¢•bl• fft the UK cl {FRS 1(r2) the CoNyi•i kt 2006. Carur Chty me* d•finiticffl of a benefit entity ￿dar FRS 102. Assds aTrJ li￿1118$ are inliaty recognised at IM$tOfical c¥*t or Vakn un19SS Oth8rnige 8tated in the relevant 12 Incom• The recognttlon ol I￿* frcm lewies 18 on 8staNishry entiuorrt the kvobo￿llty of ¢elpt IIKI lo tstim* *ilh suffiaent thg arn￿ I￿r￿ats￿. E￿d￿¢t of eniuement to a legacy exists Ythen the Company $fft"￿t ewd•nce that a grfl has been left to them kTh7hl8dg8 of Ihe exi#m of a vald ar¥J the dgah of b8nefactorl ar￿ th8 eYe￿rtor is satisffied that Ihe Pr￿ ￿111 not be reqwr8d to sabsfy daims in Ihe •ststa. RiX•Pt of a legacy must be rewised when it is wobai49 that It *ill be recefjved and the falr ¥4lue ol thè afflr￿nt f&￿vatIe. wll genwaly b8 ts exptrxod cath am¢yJnt to bo distrtthd lo tt use of Iho C(ynpwty of it*)) 1$ ￿0b1t48 that ben•fft ￿ be measured relabty. cordarte with the ch•￿eS SORP {FRS 102). yrwal Yo￿nte￿ tirn• 18 ￿1 reciwNd rof tho gift to ihe Company whlch Is the amount it would h•v0 t*en *rylling to pay to obtain saNices or lacmleg of ew1valer￿ benefft mwket,. a ¢W￿￿'￿a is th recY4Thsed wi expendth in Ihe of recelpL i￿¢￿• is receivable. Page 14 ARK CANCER CHARirY IA Comp•ny Un*d ty Guarnnt••l NOTES TO THE FINANCIAL STATEIIENTS FOR THE YEAR ENDED 31 DECEMBER 2023 Aceountlng pollcl•s l¢ontlnu•d 2.3 Exp•ndltur• Exr*rM*twe is 0￿¢ tlwa is a ¢￿tr￿ I*￿gatiOn to transfvr aconomic benefit ID a tr¥rd patty. prc*able that a trar￿f￿r of economic benefits will b8 required in $8ttJ8ment ￿ the am0￿* of tho otAig*ion Can bo rn￿1¢d ￿lIablY. Expenditurn 1$ dassifiod by aclNty. Th o)sts of eath ￿"¥rty are made up ollhe t￿1 ol c>Jsts and shared costs, induding supp¢xt costs invL*i8d in undgrtathg a¥th activly. &'recl cc*ts attrf￿rtats￿ to a slngle aclivlty ar• allc¢ated dlreclly to that a¢tivity. Shared &)sts wlM¢h conlritrth to More than one acbvty and sw)p costs vthich we not atlribJtabl8 lo a siThJJe actlvty are apportionod befv￿ those acllvlties on basis conslstent with the use of resour¢e8. Cefttr￿ *aff costs are alltxated on th¢ b￿18 of b'me 8pert, dèyeuatson &wge$ a*x*d ¢)n the ofthe a$￿t'S use. ExpeTrjit￿O on rai*NJ Irthths I￿rred by tho Company to rai8e furKls its ExpencltLTh on thaiitable aclivthes is incur￿1 on direcfjy uTrJ8rWng I1￿ athifies whkh fither tho Comparrfs thI￿tiVes. as *wll as arry asKKiaW supm costs. Grants payable are rt￿r9ed in thè year ￿ the offer 1$ made tx¢èpt in those cases where tha offer is conditional. such reccgised as exFerMlilure thlw the ￿dI￿orts attathing are lfillad. Grants offw8d subA'•cI to cfyThdth"¢)ns have not m8t at tho year end ￿ not•d ¢>Jmmitmert bLrt nol atXrU￿ 8$ eXptrndrtu￿. 2.4 Int•rn•l v•¢•l¥ab Int•r￿ ￿ fvnd$ W on knht is indudgd 7*then rKe1val￿ and amowrt ￿ be measured reliatty by tt)e Company.. this is rA)mwly UPDn ThAificatson of the wrterest paid or payable by the 2.S TangllA• ￿•￿ and dqprnckntkni Twffjlble ffixed as￿ ar8 ffecow4s•d at OXL Aft•r re￿graI1¢n. the cost model, tangible fixod assots aro mBaswed at cost 18ss XCUM￿atod (W•Jation any accumulal•d inpair￿Trt losM$. All ¢o#s rKw•d lo a tanyble fixed asset into it8 Snlended workir4J corKIitKn sho￿1 be induded in measuremert ofc06L At eath date the C¢mpwy assesses ***ther there 1$ any ￿d￿litin of imwmwnt. If su¢h vmlicalion èxists. th• r•cn Misollaneous ¢o*s 3.624 487 6290 R•charg•d 8tsy co81$ Staikngry 21.024 1.189 706 T*hon 11.976 6.￿7 20.476 34,087 An•ly#l# efgrnnts 13ranty In•titutloths 2023 Totsl funds 2023 Grwts to Ham￿*re HO¥￿815 NHS Tn•l Ihè W2llbewig C&*re 10.388 1Q.366 Grnnls to 2022 2022 Grnnts lo Hampshn P105p*as NHS Tru81 kn vrKAtafth• V4Wlbery C•ntre 167.539 167,539 P•30 20 ARK CANCER CHARITY IA Con¥•f•y Umlt•d by Gu¥ants• NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 ¥vJepond•rt oxaminefs rwrnJr*r*kn to ￿ 1th￿danI ownin8r fa• of £327012022. 10. TnMi••¥' r•ftwn•rntlon and •xpMM• Dwng Ihe y￿r erthd 31 lknbW2￿l3. no TnMt•• •xp•nw hav• boen incurrod (2022. ÈNIU. P4• 21 ARK CANCER CHARITY Corywny uffltt￿ by Guarnnts•} NOTES TO THE FINANCIAL STATEMENrJ FOR YEAR ENDED 31 DECEMBER 2023 11. Tarylbk b7x￿ ass•ts C¢mputgr equlpm•rt Co•t orYalu4llon At 1 Janu¥y 2023 Additions Di8POSa 6,33S At 31 D￿mber 2023 gM69 Deprttlaiion At 1 J•nwi 2023 Chwge for th ye (kn dsposal$ 4084 1.125 At 31 2023 2,659 M•t l)ook ￿lu• Al 31 D¢e¢n*w 2023 7.010 At31 0￿en￿r2022 12. D•btorn 2023 2022 9.13B 9,053 ARK CANCER CHARITY IA Gompany Umltsd ty Gu*rattte•) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEM8ER 2023 13. Curr•ne asset Inveslmonts 2023 Tem) depos* accounts 2,068,596 2.CV2,0115 14. Cr•dltors: Amounts falllng du• TAlthln on• year 97A58 t83, T88 P•ge 23 ARK CANCER CHAIOTY NOTES TO THE FINANCIAL STATEME14TS F(* THE YEAR ENDED 31 DECElJlaER 2023 16. Stst•m•nt Ol￿ndS Stst•m•nt oltsnds-¢uvr•nt year Balane• al 31 Balanu at 1 January 2023 Incomo Eyndltsr• 2023 Unr•gtrlcl•d funds D•slgnatsd funds Th• Wdlbairy Cantre Ral)tiw Unit Proiact Im.OOD 1.600,000 110.366 919.634 {108.246) 1.391.76S {118,6111 I381A89 G•n•Tal fund¥ Genernl ILmds 160. 137.032 {23,09 274.52• Tot•1 Unr••trlct•d fund• 1660.58T 137.032 1141,7011 2,6$5,918 P￿• 24 ARK CAMCER cTrwiirrY IA Company Llmll•d ty GuaTants•) NOTES TO THE FINANCIAL STATEMEiirs FOR THE YEAR ENDEO 31 DECEMBER 2023 15. Stalement olfunds Icontlnued) Stalemert ol funds. prlorymr 8818ncg 81 31 Trnnsfe￿ E*L¥mb8r 20Y l January Unrn¥trlct•d fvnds l>•slgnat•d fvnd8 The We￿Ing Centre Rainb(MT Urmt Propcl I.5￿.Cly1 I.590.Cts) I,Lxk),Lx￿ i.000.L 2500.1￿ 2.500.OC Gèftvrnl funds 2710.642 154.T30 (201.785) {2.sL￿.OL￿j 160.587 Tot•1 Unrn•tr1￿ fund# 2,710,642 154. (204.785) 2,66Q￿7 P*Je 25 ARK CANCER CHAIIITY NOTES TO THE FIIIANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2Q23 1& ollund¥ Summary oftsnd¥. curntyoar Balan￿ at 31 Balanc• at 1 January 2023 Incom• Exp•ndltur• Oesignated fffids General fvnds Isoo,000 160,687 {118.811) 2,311, (23,0gD) 274529 137,032 1660.587 I37￿32 1141.701) 2.655,918 Sunxnary of fvnrfs. prlory•*r Balan￿ at 31 l Janu 2022 Clesiglated Z710,642 f54.T30 (204.78S) (2.500.QX)) 160.587 2710.642 154.7 (204.785) 2,660,587 17. AN￿1& ot not assels b•lw•w fvnds fvnds 2L12J fvnd• 2023 T*ble fred a8￿ts Cuffent assd$ Cf•litors due NK* 7,010 7.010 2.746.366 &748,360 {97.458) 197,4681 2.655,918 2.656.918 ARK CANCER CHARrr (A Company Urntt￿ ty Gu*rnnts•) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 18. Op•r*dng l•as• ¢onwnltmonts At 31 t)ecember 2023 Cc•npwy hwj Ixxnmitrnents to rn*• mkimum l¥se pasffnents )n4anc•latl• cpwaing lus8s •s frknts: 2022 Equlpm•nt )t lalw than 1 yew L*rth￿ 1 yew and not lal8r 5 ye¥s 1.250 1.133 1,487 2.384 2A83 3,871 19. M•mb•rs' Ilablllty Eath mgmbgr of the thrilable CcThp8ny ￿d￿￿koS to contsknuk tt) the assets of the Company in th• event of 6t belng W￿nd ￿ vkniJ8 h8lsho is a mèmbw. or wthin year aftèr Iwl$he ceases lo be member. suth amount as nw b¢ rowr•J. rw)t ￿ £1 for th& dg1)ts l1obm￿•s CC4ttfacied b8forg helsh• to bè a member. R•lit•d party tTans•ctlons 21. Post balanc• ¥hMt•v•nts SirKe thfr balarKe sheet date. Ihe cha￿ of a furtrw £95,000 legacy was received in Jly 2024. Controlllng p•rty t￿rir￿J the year. tt)8 chkn was Lntsthe d1he Tn*tee¥. Page 27 NOTES TO THE FINANCIAL STATEMENTS FCI? THE YEAR ENDED 31 DECWER 2023 C¢ynmon Tnjst confinn&ts rt wrAAY matdFfwd thations for tha Ath Chaiity rf th• thaticry were put thrcmjgh their Fr&mfr&(>anl' p￿ta. Ihts evofved knlo The G￿rt Ex￿￿nge. The matsh funding was Set on a basis ofa 1.1 ratio to maximum of£500.C(thJ.The Axk Chty rea**ed thls m8tCl￿fvndIng goal in NfNomber 2017. The m*thed fundng Pa￿ frryn Greenh•n Comnw)n Tn*t thill be r•*ed to the tharity ￿ rtteipt of a c¢py COM￿￿￿ Crytificale. Ralntthv ithf¢ refurbislvnwrt Frfol￿t 2024. Page 28